Suppr超能文献

肺动脉高压协会认证的综合护理中心中肺动脉高压患者的特征:与美国国家注册数据相比的特征对比

Characteristics of Patients With Pulmonary Arterial Hypertension in a Pulmonary Hypertension Association-Accredited Comprehensive Care Center: A Contrast in Features When Compared With US National Registry Data.

作者信息

Ingram Dominique, Alamri Ayedh K, Penn Brittany A, Mayeux Jennalyn D, Ma Christy L, Clapham Katharine R, Abraham Anu E, Klanderud Dana, Sadeh Ben, Beck Emily M, Hatton Nathan D, Ryan John J

机构信息

Cardiovascular Medicine, University of Utah, Salt Lake City, USA.

Department of Medicine, College of Medicine, Northern Border University, Arar, SAU.

出版信息

Cureus. 2022 Nov 21;14(11):e31764. doi: 10.7759/cureus.31764. eCollection 2022 Nov.

Abstract

Background Since the initial description in the 1980s, our understanding of the diversity of pulmonary arterial hypertension (PAH) has continued to evolve. In this study, we report the characteristics of patients seen in an academic medical center for PAH from August 2020 through November 2021 and contrast those with nationally reported data from the United States Pulmonary Hypertension Scientific Registry (USPHSR).  Study Design Investigators at the University of Utah Pulmonary Hypertension Program prospectively enrolled adult patients diagnosed with WHO Group 1 PAH, who were evaluated between August 2020 and November 2021 in a program-specific registry. Patient exposure and health histories were collected through structured interviews and questionnaires, along with clinical data and medication use. A total of 242 patients were enrolled in the University of Utah Pulmonary Hypertension Registry (UUPHR).  Results Of the 242 enrolled patients, the most common etiology was associated PAH (APAH), accounting for 71.1% of the population. The second largest etiology was idiopathic PAH (IPAH) at 26.4%. The remaining patients were distributed between familial PAH (FPAH), pulmonary veno-occlusive disease (PVOD), and others. Of the total population classified as APAH, 39% of cases were noted as secondary to connective tissue disease (CTD) and 33% as toxin-induced. These represented 28% and 24% of the total population, respectively.  Conclusions In this US-based accredited academic medical center, the etiology of PAH in our patient population contrasts with national registry data. In the UUPHR, APAH, specifically CTD-PAH and toxin-associated PAH, accounts for the majority of patients with PAH. This contrasts with IPAH, which nationally is the most reported cause of PAH. Differences in our population may reflect the regional variation of the referral site, but it is noteworthy for its contrast with historically reported phenotypes.

摘要

背景 自20世纪80年代首次描述以来,我们对肺动脉高压(PAH)多样性的认识一直在不断发展。在本研究中,我们报告了2020年8月至2021年11月在一家学术医疗中心就诊的PAH患者的特征,并将其与美国肺动脉高压科学注册中心(USPHSR)报告的全国数据进行对比。 研究设计 犹他大学肺动脉高压项目的研究人员前瞻性地招募了被诊断为世界卫生组织第1组PAH的成年患者,这些患者于2020年8月至2021年11月在特定项目注册中心接受评估。通过结构化访谈和问卷收集患者的暴露情况和健康史,以及临床数据和用药情况。共有242名患者被纳入犹他大学肺动脉高压注册中心(UUPHR)。 结果 在242名登记患者中,最常见的病因是相关性PAH(APAH),占总人数的71.1%。第二大病因是特发性PAH(IPAH),占26.4%。其余患者分布在家族性PAH(FPAH)、肺静脉闭塞性疾病(PVOD)和其他疾病之间。在归类为APAH的总人口中,39%的病例被指出继发于结缔组织病(CTD),33%为毒素诱导。这些分别占总人口的28%和24%。 结论 在这家位于美国的经认可的学术医疗中心,我们患者群体中PAH的病因与国家注册数据不同。在UUPHR中,APAH,特别是CTD-PAH和毒素相关性PAH,占PAH患者的大多数。这与IPAH形成对比,在全国范围内,IPAH是报告最多的PAH病因。我们患者群体的差异可能反映了转诊地点的区域差异,但值得注意的是,它与历史报告的表型形成了对比。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9718/9772347/0a871a11f291/cureus-0014-00000031764-i01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验